Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
Abstract Broadly neutralizing antibodies (bNAbs), able to prevent viral entry by diverse global viruses, are a major focus of HIV vaccine design, with data from animal studies confirming their ability to prevent HIV infection. However, traditional vaccine approaches have failed to elicit these types...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMC
2018-09-01
|
| Sarja: | Retrovirology |
| Linkit: | http://link.springer.com/article/10.1186/s12977-018-0443-0 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|